Caution, This content is for veterinary professionals.

VETERINARY HPM® Kidney Support Cat

Renal insufficiency


Clinical Indications*
• Support of renal function in case of chronic renal insufficiency (or temporary).

Available formats: 1.5 kg, 3 kg

 

OTHER USE Cat-Kidney-1.png

  • Chronic hepatic disorder

CONTRAINDICATIONS

  • Growth
  • Gestation and lactation

 

KEY BENEFITS & CHARACTERISTICS

Low Phosphorus*

Low dietary phosphorus helps slow down the development of renal disease and minimise the risk of secondary hyperparathyroidism.

Restricted Protein Level*

Restricted level and the high quality of protein helps reduce the production of uremic toxins while maintaining sufficient kidney fluid turn over and body condition.

Phosphorus Binding

Addition of Phosphorus binders (chitosan and calcium carbonate) helps reduce the phosphorus bioavailability (clinically proven by Virbac)(1)

High Energy Density & Palatability

High energy density helps deliver small and concentrated daily rations, and high palatability helps maintain sufficient daily food intake, to support patients against undernutrition.

High EPA+DHA

High level of omega-3, especially EPA + DHA, helps modulate inflammatory processes in the kidney.

 

Cat-Kidney-1.png

 

 

ADDITIONAL BENEFITS & CHARACTERISTICS

Increases Antioxidant Activity

High level of vitamin E helps promote antioxidant activity.

Limits the risk of FLUTD

Adjusted RSS for struvite and oxalate help maintain urinary health.

Limits the risk of Digestive Ulcerations

Addition of Montmorillonite helps protect the digestive mucosa against damage linked to uremia.

Limits the risk of Metabolic Acidosis

Addition of alkalising agents (calcium carbonate) helps limit the risk of metabolic acidosis.

Limits the risk of Hyperparathyroidism

Increased calcium, with Ca:P ratio = 2, helps limit the side effect of high phosphataemia and limit the risk of hyperparathyroidism.

Limits the risk of Hypokalaemia

Increased dietary potassium content helps compensate for urinary losses and limit the risk of hypokalaemia.

Suitable for Adult and Senior cats

The amounts of all essential nutrients fit the daily requirement of adult and senior cats.

 

 

 

 

 

Composition and technical specifications

 

ANALYTICAL CONSTITUENTS (% as fed)

  • Moisture 5.5
  • Protein 30
  • Animal to vegetable ratio 68/32
  • Fat 21
  • Minerals 6.5
  • Crude Fibre 4
  • NFE 33
  • Starch 26
  • Calcium 0.9
  • Phosphorus 0.45
  • Sodium 0.4
  • Potassium 0.8
  • Omega-6 fatty acids 3.5
  • Omega-3 fatty acids 1.1
  • EPA+DHA 0.4

COMPOSITION

Dehydrated pork and poultry proteins(1), rice, animal fats, peas, potato starch, minerals, potato protein(1), hydrolysed pork and poultry proteins(1), beet pulp, lignocellulose, fish oil, linseed, brewers yeast, fructo-oligosaccharides, hydrolysed crustacean (source of chitosan), chondroitin sulfate, Lactobacillus acidophilus.
1) Protein sources

 

KEY NUTRIENT VALUES

  • Metabolisable energy (kcal/100g) 415
  • Measured metabolisable energy (kcal/100g) 414
  • Protein digestibility (in vivo; %) 88.5
  • Fat digestibility (in vivo; %) 93
  • Energy from protein (%) 26
  • Energy from fat (%) 45
  • Energy from NFE (%) 29
  • Protein to Calorie ratio (g/Mcal) 72

 


 

 

SPECIFIC INGREDIENTS/ADDITIVES

● Bentonite 5 mg/kg
● Pasteurised Lactobacillus acidophilus 7 mg/kg
● Chitosan 800 mg/kg
● Calcium carbonate 1.5%
● L-caritine 540 mg/kg

 

Veterinary Global Care

Cat-Kidney-1.png

 

Management of primary condition

Chronic Kidney Disease Management

  • Low dietary phosphorus content (0.45%) and added phosphorus binders (chitosan, calcium carbonate) help reduce phosphorus bioavailability. (efficacy proven by Virbac)1
  • Helps reduce uremic toxins: The high biological value of proteins (amino acid profile) favours the integration of amino acids into the anabolism processes and therefore reduces catabolism.
  • The high EPA+DHA content (0.4%) helps modulate inflammatory processes in the kidneys.
  • Addition of antioxidant: The richness in vitamin E (610 mg/kg) helps reduce oxidative processes.
  • Limits the risk of digestive ulcerations: Added Montmorillonite (0.5%) helps protect the digestive mucosa against damage linked to uremia.

 

Management of concurrent conditions

Denutrition management:

  • The high energy density (calculated 401 kcal/100g, measured: 414 kcal/100g), thanks to high fat level (21%), and the high digestibility of nutrients allow to propose small concentrated daily rations and help maintain optimal body weight.
  • High palatability: The choice of ingredients, mainly of animal origin, favours food intake

Helps limit the risk of:

  • Secondary Hyperparathyroidism: Increased dietary calcium intake (0.9%) allows to achieve Ca:P ratio= 2 and limit the side-effect of high phosphatemia.
  • Metabolic acidosis: The addition of alkalising agent (calcium carbonate) increases the pH in the body fluids.
  • Hypokalaemia: Increased dietary potassium intake (0.8%) compensates for urinary losses and limits the risk of hypokalaemia.
  • Lower urinary tract disease: Adjusted RSS for struvite and oxalate help maintain urinary health.

 

Maintenance of body composition 

 

Limits muscle loss: The restricted, but sufficient dietary protein content (30%) and the high quality of protein (in vivo apparent digestibility coefficient: 88.5%) help maintain muscle mass.

 

Additional health benefits

High digestive tolerance:

  • The addition of Montmorillonite, Lactobacilli, lignocellulose and FOS helps maintain a healthy digestive tract (mucosa, microflora, motility and transit).

Skin & Coat Support:

  • The protein content (30%), especially of animal origin (72%), and the high and balanced omega-6 (3.5%) and omega-3 (1.1%) fatty acids help maintain healthy skin and shiny coat.

Withdrawal of major allergens:

  • The diet is made without beef, gluten, maize, wheat, soya, egg, and dairy products.

 

 

 

References

Commission Directive 2008/38/EC

  1. Leriche I., Gely MO., Nguyen P. Effect of chitosan supplementation in a dry maintenance diet on phosphorus apparent digestibility in cats. SEVC Congress, Barcelona, Spain, 15-17 Oct 2015.